This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

CHARLES F. GESCHICKTER, M.D.; MURRAY M. COPELAND, M.D.; JOSEPH COLT BLOODGOOD, M.D.

Arch Surg. 1929;19(2):169-271.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

FOREWORD

First, I would like to acknowledge our indebtedness to Mrs. Carl Joerissen, of Washington and Paris, and to those former patients and friends who contributed to the fund that made this research possible.

These two research fellows, Dr. Charles F. Geschickter and Dr. Murray M. Copeland, in the Surgical Pathological Laboratory of the Johns Hopkins University, began an independent study of multiple myeloma during the early spring of 1927, their senior year in the medical school, and continued their research in the laboratory and in the library. These studies were published in the ARCHIVES OF SURGERY in the April, 1928, issue, page 807.

During this time, they reviewed the entire collection of bone material in the laboratory, and thus prepared themselves for the more intensive study of all lesions of bone and all benign and malignant connective tissue tumors, beginning in July, 1928. Two papers are ready for publication; . . . [Full Text PDF of this Article]

Author Affiliations
Research Fellows of the Bloodgood Cancer Research Fund, in the Surgical Pathological Laboratory, the Johns Hopkins Hospital and University; BALTIMORE

Footnotes
Submitted for publication, Dec. 17, 1928.

Publication aided by grant from the fund of the Hartley Corporation.

Illustrations by Mr. Herman Schapiro.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?